CEL-SCI Corp
CVM7.340USD
+0.280+3.97%
收盤 11/05, 16:00（美東）報價延遲15分鐘
39.06M總市值
虧損本益比TTM
關於 CEL-SCI Corp 公司
CEL-SCI Corporation 是一家處於臨牀後期的生物技術公司。該公司從事旨在利用免疫系統（人體的天然防禦系統）改善癌症和其他疾病治療的研究和開發。該公司專注於開發候選產品和技術，包括 Multikine 和配體表位抗原呈遞系統技術 (LEAPS)。Multikine（白細胞白細胞介素注射液）是一種真正的一線癌症療法，旨在幫助免疫系統在免疫系統仍然相對完整並因此被認爲能夠更好地攻擊腫瘤時瞄準腫瘤。LEAPS 旨在刺激人體免疫系統更有效地對抗細菌、病毒和寄生蟲感染以及自身免疫性疾病、過敏、移植排斥和癌症，而這些是人體免疫系統無法自行完成的。LEAPS 候選產品包括 CEL-2000、CEL-4000 和 DerG-PG275(Cit)（又名 CEL-5000）。
CEL-SCI Corp簡介
公司代碼CVM
公司名稱CEL-SCI Corp
上市日期Dec 08, 1983
CEOMr. Geert R. Kersten, Esq.
員工數量- -
證券類型Ordinary Share
年結日Dec 08
公司地址Suite 802
城市VIENNA
上市交易所NYSE American Consolidated
國家United States of America
郵編22182
電話17035069460
網址https://cel-sci.com/
公司代碼CVM
上市日期Dec 08, 1983
CEOMr. Geert R. Kersten, Esq.
CEL-SCI Corp公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Geert R. Kersten, Esq.
Mr. Geert R. Kersten, Esq.
Chief Executive Officer, Chief Financial Officer, Treasurer, Director
Chief Executive Officer, Chief Financial Officer, Treasurer, Director
73.41K
+0.78%
Ms. Patricia B. Prichep
Ms. Patricia B. Prichep
Co-Chief Financial Officer, Chief Operating Officer, Corporate Secretary
Co-Chief Financial Officer, Chief Operating Officer, Corporate Secretary
11.21K
+4.34%
Dr. Eyal Talor, Ph.D.
Dr. Eyal Talor, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
5.81K
+4.69%
Mr. Robert Eugene (Bob) Watson
Mr. Robert Eugene (Bob) Watson
Independent Chairman of the Board
Independent Chairman of the Board
3.73K
+358.60%
Mr. Bruno Jean-Marie Baillavoine
Mr. Bruno Jean-Marie Baillavoine
Independent Director
Independent Director
199.00
--
Mr. John Cipriano
Mr. John Cipriano
Senior Vice President - Regulatory Affairs
Senior Vice President - Regulatory Affairs
--
--
Mr. Mario Gobbo, Ph.D.
Mr. Mario Gobbo, Ph.D.
Independent Director
Independent Director
--
--
Dr. Daniel H. Zimmerman, Ph.D.
Dr. Daniel H. Zimmerman, Ph.D.
Senior Vice President - Research, Cellular Immunology
Senior Vice President - Research, Cellular Immunology
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Geert R. Kersten, Esq.
Mr. Geert R. Kersten, Esq.
Chief Executive Officer, Chief Financial Officer, Treasurer, Director
Chief Executive Officer, Chief Financial Officer, Treasurer, Director
73.41K
+0.78%
Ms. Patricia B. Prichep
Ms. Patricia B. Prichep
Co-Chief Financial Officer, Chief Operating Officer, Corporate Secretary
Co-Chief Financial Officer, Chief Operating Officer, Corporate Secretary
11.21K
+4.34%
Dr. Eyal Talor, Ph.D.
Dr. Eyal Talor, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
5.81K
+4.69%
Mr. Robert Eugene (Bob) Watson
Mr. Robert Eugene (Bob) Watson
Independent Chairman of the Board
Independent Chairman of the Board
3.73K
+358.60%
Mr. Bruno Jean-Marie Baillavoine
Mr. Bruno Jean-Marie Baillavoine
Independent Director
Independent Director
199.00
--
Mr. John Cipriano
Mr. John Cipriano
Senior Vice President - Regulatory Affairs
Senior Vice President - Regulatory Affairs
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 10月23日 週四
更新時間: 10月23日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Lincoln Alternative Strategies LLC
6.94%
The Vanguard Group, Inc.
2.29%
Commonwealth Financial Network
2.19%
BlackRock Institutional Trust Company, N.A.
1.43%
Kersten (Geert R)
0.92%
其他
86.23%
持股股東
持股股東
佔比
Lincoln Alternative Strategies LLC
6.94%
The Vanguard Group, Inc.
2.29%
Commonwealth Financial Network
2.19%
BlackRock Institutional Trust Company, N.A.
1.43%
Kersten (Geert R)
0.92%
其他
86.23%
股東類型
持股股東
佔比
Corporation
6.94%
Investment Advisor
6.69%
Individual Investor
1.26%
Investment Advisor/Hedge Fund
1.14%
Research Firm
0.54%
其他
83.43%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
122
669.31K
8.37%
+310.99K
2025Q2
130
280.62K
4.34%
-122.18K
2025Q1
141
362.72K
6.33%
+7.45K
2024Q4
154
8.90M
11.54%
-654.04K
2024Q3
159
7.92M
12.84%
-1.82M
2024Q2
170
8.27M
15.20%
-2.00M
2024Q1
223
9.54M
17.62%
-953.00K
2023Q4
231
8.54M
17.00%
-1.14M
2023Q3
241
7.38M
15.57%
-2.53M
2023Q2
252
7.44M
15.71%
-2.96M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Lincoln Alternative Strategies LLC
555.00K
6.94%
+555.00K
--
Aug 27, 2025
The Vanguard Group, Inc.
183.21K
2.29%
+104.78K
+133.58%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
114.25K
1.43%
+88.15K
+337.80%
Jun 30, 2025
Kersten (Geert R)
73.41K
0.92%
+570.00
+0.78%
Sep 30, 2025
MAI Capital Management, LLC
64.93K
0.81%
+47.38K
+270.01%
Jun 30, 2025
BofA Global Research (US)
40.98K
0.51%
+40.92K
+68201.67%
Jun 30, 2025
UBS Financial Services, Inc.
29.82K
0.37%
+26.88K
+914.18%
Jun 30, 2025
Geode Capital Management, L.L.C.
25.92K
0.32%
+821.00
+3.27%
Jun 30, 2025
Osaic Holdings, Inc.
15.53K
0.19%
+5.89K
+61.17%
Jun 30, 2025
查看更多
持股ETF
更新時間: 2 小時前
更新時間: 2 小時前
機構名稱
佔比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
